- Home
- VMAR vs AEON Comparison
VMAR vs AEON Comparison
Compare VMAR & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VMAR
- AEON
- Stock Information
- Founded
- VMAR 1995
- AEON N/A
- Country
- VMAR Canada
- AEON United States
- Employees
- VMAR N/A
- AEON N/A
- Industry
- VMAR Marine Transportation
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- VMAR Industrials
- AEON Health Care
- Exchange
- VMAR Nasdaq
- AEON Nasdaq
- Market Cap
- VMAR 5.1M
- AEON 5.7M
- IPO Year
- VMAR 2020
- AEON N/A
- Fundamental
- Price
- VMAR $7.42
- AEON $0.82
- Analyst Decision
- VMAR Strong Buy
- AEON Strong Buy
- Analyst Count
- VMAR 1
- AEON 1
- Target Price
- VMAR $2,700.00
- AEON $360.00
- AVG Volume (30 Days)
- VMAR 32.6K
- AEON 1.9M
- Earning Date
- VMAR 07-14-2025
- AEON 05-14-2025
- Dividend Yield
- VMAR N/A
- AEON N/A
- EPS Growth
- VMAR N/A
- AEON N/A
- EPS
- VMAR N/A
- AEON 73.23
- Revenue
- VMAR $1,612,492.00
- AEON N/A
- Revenue This Year
- VMAR N/A
- AEON N/A
- Revenue Next Year
- VMAR $264.29
- AEON N/A
- P/E Ratio
- VMAR N/A
- AEON $0.01
- Revenue Growth
- VMAR N/A
- AEON N/A
- 52 Week Low
- VMAR $4.04
- AEON $0.38
- 52 Week High
- VMAR $1,025.33
- AEON $269.28
- Technical
- Relative Strength Index (RSI)
- VMAR 52.71
- AEON 67.31
- Support Level
- VMAR $6.81
- AEON $0.53
- Resistance Level
- VMAR $8.17
- AEON $0.85
- Average True Range (ATR)
- VMAR 0.69
- AEON 0.08
- MACD
- VMAR 0.02
- AEON 0.05
- Stochastic Oscillator
- VMAR 45.52
- AEON 92.78
About VMAR Vision Marine Technologies Inc.
Vision Marine Technologies Inc is in the business of designing and manufacturing electric outboard powertrain systems, power boats, and related technology and the renting of electric boats. The different models of the powerboats and electric boats manufactured by the company include Bruce 22, Fantail 217, Volt 180, and others. The company operates in two reportable business segments; Sale of electric boats and Rental of electric boats. The majority of the revenue for the company is generated from the Sale of electric boats segment. Geographically, the company generates revenue from its business in Canada, USA and other countries. A substantial portion of the overall revenue is generated from its business in USA.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.